GB0505781D0 - Chemical compounds - Google Patents
Chemical compoundsInfo
- Publication number
- GB0505781D0 GB0505781D0 GBGB0505781.5A GB0505781A GB0505781D0 GB 0505781 D0 GB0505781 D0 GB 0505781D0 GB 0505781 A GB0505781 A GB 0505781A GB 0505781 D0 GB0505781 D0 GB 0505781D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- chemical compounds
- compounds
- isocladribine
- clofarabine
- cladribine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Genetics & Genomics (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Priority Applications (22)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0505781.5A GB0505781D0 (en) | 2005-03-21 | 2005-03-21 | Chemical compounds |
SI200630762T SI1866324T1 (sl) | 2005-03-21 | 2006-03-16 | Fosforamidni derivati nukleotidnih sestavkov za uporabo pri zdravljenju raka |
PL06710096T PL1866324T3 (pl) | 2005-03-21 | 2006-03-16 | Fosforamidanowe pochodne związków nukleozydowych do stosowania przy leczeniu raka |
DK06710096.6T DK1866324T3 (da) | 2005-03-21 | 2006-03-16 | Phosphoramidatderivater af nukleosidforbindelser til anvendelse i behandlingen af cancer |
CNA200680016708XA CN101175763A (zh) | 2005-03-21 | 2006-03-16 | 用于治疗癌症的核苷化合物的氨基磷酸酯衍生物 |
DE602006014949T DE602006014949D1 (de) | 2005-03-21 | 2006-03-16 | Phosphoramidatderivate von nukleosidverbindungen zur verwendung bei der behandlung von krebs |
MX2007011666A MX2007011666A (es) | 2005-03-21 | 2006-03-16 | Derivados de fosforamidato de compuestos nucleosidicos para el uso en el tratamiento del cancer. |
PT06710096T PT1866324E (pt) | 2005-03-21 | 2006-03-16 | Derivados de fosforamidato de compostos de nucleósido para utilização no tratamento do cancro |
CN201410186829.5A CN103936807A (zh) | 2005-03-21 | 2006-03-16 | 用于治疗癌症的核苷化合物的氨基磷酸酯衍生物 |
BRPI0609704A BRPI0609704B8 (pt) | 2005-03-21 | 2006-03-16 | compostos derivados de fosforamidato, seus usos, composições farmacêuticas que os compreendem, métodos de preparação das referidas composições e processo para preparação de um composto |
CA2602324A CA2602324C (en) | 2005-03-21 | 2006-03-16 | Phosphoramidate derivatives of nucleoside compounds for use in the treatment of cancer |
EP06710096A EP1866324B1 (en) | 2005-03-21 | 2006-03-16 | Phosphoramidate derivatives of nucleoside compounds for use in the treatment of cancer |
ZA200709011A ZA200709011B (en) | 2005-03-21 | 2006-03-16 | Phosphoramidate derivatives of nucleoside compounds for use in the treatment of cancer |
AU2006226182A AU2006226182C1 (en) | 2005-03-21 | 2006-03-16 | Phosphoramidate derivatives of nucleoside compounds for use in the treatment of cancer |
US11/886,931 US8263575B2 (en) | 2005-03-21 | 2006-03-16 | Phosphoramidate derivatives of nucleoside compounds for use in the treatment of cancer |
PCT/GB2006/000932 WO2006100439A1 (en) | 2005-03-21 | 2006-03-16 | Phosphoramidate derivatives of nucleoside compounds for use in the treatment of cancer |
AT06710096T ATE471334T1 (de) | 2005-03-21 | 2006-03-16 | Phosphoramidatderivate von nukleosidverbindungen zur verwendung bei der behandlung von krebs |
JP2008502453A JP5345381B2 (ja) | 2005-03-21 | 2006-03-16 | 癌の治療における使用のためのヌクレオシド化合物のホスホルアミデート誘導体 |
ES06710096T ES2348741T3 (es) | 2005-03-21 | 2006-03-16 | Derivados de fosforamidato de compuestos nucleosidos para uso en el tratamiento del cancer. |
IL186104A IL186104A (en) | 2005-03-21 | 2007-09-20 | Phosphoramidate History of Nucleoside Compounds |
CY20101100826T CY1111538T1 (el) | 2005-03-21 | 2010-09-10 | Φωσφοραμιδικα παραγωγα νουκλεοζιτικων ενωσεων για χρηση στην αντιμετωπιση καρκινου |
JP2013097919A JP5863702B2 (ja) | 2005-03-21 | 2013-05-07 | 癌の治療における使用のためのヌクレオシド化合物のホスホルアミデート誘導体 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0505781.5A GB0505781D0 (en) | 2005-03-21 | 2005-03-21 | Chemical compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0505781D0 true GB0505781D0 (en) | 2005-04-27 |
Family
ID=34531603
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB0505781.5A Ceased GB0505781D0 (en) | 2005-03-21 | 2005-03-21 | Chemical compounds |
Country Status (20)
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2012216500B2 (en) * | 2006-11-24 | 2013-06-20 | Katholieke Universiteit Leuven | Nucleoside aryl phosphoramidates and their use as anti-viral agents for the treatment of hepatitis C virus |
GB0623493D0 (en) | 2006-11-24 | 2007-01-03 | Univ Cardiff | Chemical compounds |
US8173621B2 (en) | 2008-06-11 | 2012-05-08 | Gilead Pharmasset Llc | Nucleoside cyclicphosphates |
PA8855701A1 (es) | 2008-12-23 | 2010-07-27 | Análogos de nucleósidos | |
WO2010075554A1 (en) | 2008-12-23 | 2010-07-01 | Pharmasset, Inc. | Synthesis of purine nucleosides |
EA019341B1 (ru) | 2008-12-23 | 2014-02-28 | Джилид Фармассет, Ллс. | Фосфорамидаты нуклеозидов |
KR20110120886A (ko) | 2009-01-09 | 2011-11-04 | 유니버시티 칼리지 오브 카디프 컨설턴트 리미티드 | 바이러스 감염 치료용 구아노신 뉴클레오사이드 화합물의 포스포라미데이트 유도체 |
BR112012024884A2 (pt) | 2010-03-31 | 2016-10-18 | Gilead Pharmasset Llc | síntese estereosseletiva de ativos contendo fósforo |
GB201016855D0 (en) * | 2010-10-06 | 2010-11-17 | Nucana Biomed Ltd | Chemical compounds |
WO2012092484A2 (en) * | 2010-12-29 | 2012-07-05 | Inhibitex, Inc. | Substituted purine nucleosides, phosphoroamidate and phosphorodiamidate derivatives for treatment of viral infections |
CN103403014B (zh) * | 2011-01-03 | 2016-07-06 | 河南美泰宝生物制药有限公司 | O-(经取代的苯甲基)氨基磷酸酯化合物及其治疗用途 |
DK3031812T3 (en) | 2011-03-01 | 2018-09-17 | NuCana plc | CHEMICAL COMPOUNDS |
US9085599B2 (en) | 2011-03-16 | 2015-07-21 | Enanta Pharmaceuticals, Inc. | 2′allene-substituted nucleoside derivatives |
CN111592577A (zh) * | 2012-11-16 | 2020-08-28 | 努卡那公共有限公司 | 用于制备核苷前体药物的方法 |
WO2014197578A1 (en) | 2013-06-05 | 2014-12-11 | Idenix Pharmaceuticals, Inc. | 1',4'-thio nucleosides for the treatment of hcv |
AU2014354775A1 (en) | 2013-11-27 | 2016-05-19 | Idenix Pharmaceuticals Llc | Nucleotides for the treatment of liver cancer |
KR20170005492A (ko) * | 2014-05-28 | 2017-01-13 | 아이데닉스 파마슈티칼스 엘엘씨 | 암의 치료를 위한 뉴클레오시드 유도체 |
EP3149017B1 (en) * | 2014-05-28 | 2019-12-11 | Idenix Pharmaceuticals LLC | Nucleoside derivatives for the treatment of cancer |
IL291927A (en) | 2014-11-28 | 2022-06-01 | NuCana plc | Oligonucleotides containing modified nucleosides |
KR20220025914A (ko) | 2015-03-06 | 2022-03-03 | 아테아 파마슈티컬즈, 인크. | HCV 치료를 위한 β-D-2'-데옥시-2'-α-플루오로-2'-β-C-치환된-2-변형된-N6-치환된 퓨린 뉴클레오티드 |
BR112018009946A8 (pt) | 2015-11-16 | 2019-02-26 | Ichorion Therapeutics Inc | pró-fármacos de ácido nucleico |
GB201522764D0 (en) * | 2015-12-23 | 2016-02-03 | Nucana Biomed Ltd | Formulations of phosphate derivatives |
GB201609602D0 (en) * | 2016-06-01 | 2016-07-13 | Nucuna Biomed Ltd | Chemical compounds |
GB201609601D0 (en) | 2016-06-01 | 2016-07-13 | Nucana Biomed Ltd | Phosphoramidate compounds |
GB201609600D0 (en) * | 2016-06-01 | 2016-07-13 | Nucuna Biomed Ltd | Cancer treatments |
WO2018013937A1 (en) | 2016-07-14 | 2018-01-18 | Atea Pharmaceuticals, Inc. | Beta-d-2'-deoxy-2'-alpha-fluoro-2'-beta-c-substituted-4'-fluoro-n6-substituted-6-amino-2-substituted purine nucleotides for the treatment of hepatitis c virus infection |
CN116036114A (zh) | 2016-09-07 | 2023-05-02 | 阿堤亚制药公司 | 用于rna病毒治疗的2’-取代的-n6-取代的嘌呤核苷酸 |
WO2018071675A1 (en) * | 2016-10-12 | 2018-04-19 | Georgetown University | Cd99 inhibitors and their uses |
GB201709471D0 (en) | 2017-06-14 | 2017-07-26 | Nucana Biomed Ltd | Diastereoselective synthesis of hosphate derivatives |
GB201715011D0 (en) | 2017-09-18 | 2017-11-01 | Nucana Biomed Ltd | Floxuridine synthesis |
GB201720279D0 (en) | 2017-12-05 | 2018-01-17 | Nucana Biomed Ltd | Anticancer compounds |
GB201904544D0 (en) | 2019-04-01 | 2019-05-15 | NuCana plc | Anticancer compounds |
WO2021173713A1 (en) | 2020-02-27 | 2021-09-02 | Atea Pharmaceuticals, Inc. | Highly active compounds against covid-19 |
US10874687B1 (en) | 2020-02-27 | 2020-12-29 | Atea Pharmaceuticals, Inc. | Highly active compounds against COVID-19 |
CN113549076B (zh) * | 2021-07-23 | 2022-12-06 | 中国药科大学 | 一种多取代嘌呤类化合物及其制备方法和应用 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR880000094B1 (ko) | 1984-12-07 | 1988-02-23 | 보령제약 주식회사 | 뉴클레오시드 유도체의 제조방법 |
CA2004695C (en) | 1988-12-12 | 1999-08-10 | Rosanne Bonjouklian | Phospholipid nucleosides |
DE4418690A1 (de) | 1994-05-28 | 1996-01-11 | Boehringer Mannheim Gmbh | Neue Lipidester von Nucleosid-Monophosphaten und deren Verwendung als immunsuppressive Arzneimittel |
GB9505025D0 (en) * | 1995-03-13 | 1995-05-03 | Medical Res Council | Chemical compounds |
CA2675757C (en) | 1995-04-21 | 2011-03-15 | University Of South Florida | Immunopotentiating inosine monophosphate 5'-nucleotidase resistant derivatives and uses thereof |
JP3761958B2 (ja) | 1996-03-12 | 2006-03-29 | 彰 松田 | 3′−カルバモイルアルキルヌクレオシド誘導体 |
PT1045897E (pt) * | 1998-01-23 | 2002-07-31 | Newbiotics Inc | Agentes terapeuticos por catalise enzimatica |
GB9821058D0 (en) * | 1998-09-28 | 1998-11-18 | Univ Cardiff | Chemical compound |
JP4768909B2 (ja) | 2000-09-29 | 2011-09-07 | 扶桑薬品工業株式会社 | トポイソメラーゼ阻害剤 |
US20030073618A1 (en) | 2001-02-08 | 2003-04-17 | Kozhemyakin Leonid A. | Compounds comprising disulfide-containing peptides and nitrogenous bases, and medical uses thereof |
DE10108851A1 (de) * | 2001-02-23 | 2002-09-12 | Resprotect Gmbh | Verwendung von 5'-substituierten Nukleosiden und/oder deren Prodrugs zur resistenzfreien Therapie von Infektionskrankheiten |
AU2002322325A1 (en) | 2001-06-22 | 2003-01-08 | Emory University | Beta-2'-or 3'-halonucleosides |
GB0317009D0 (en) * | 2003-07-21 | 2003-08-27 | Univ Cardiff | Chemical compounds |
GB0401088D0 (en) | 2004-01-19 | 2004-02-18 | Univ Cardiff | Phosphoramidate derivatives |
EP1773355B1 (en) * | 2004-06-24 | 2014-06-25 | Merck Sharp & Dohme Corp. | Nucleoside aryl phosphoramidates for the treatment of rna-dependent rna viral infection |
EP1928475B1 (en) * | 2005-08-15 | 2018-05-23 | Riboscience LLC | Antiviral phosphoramidates of 4'-c-azido-substituted pronucleotides |
-
2005
- 2005-03-21 GB GBGB0505781.5A patent/GB0505781D0/en not_active Ceased
-
2006
- 2006-03-16 PT PT06710096T patent/PT1866324E/pt unknown
- 2006-03-16 ES ES06710096T patent/ES2348741T3/es active Active
- 2006-03-16 AU AU2006226182A patent/AU2006226182C1/en active Active
- 2006-03-16 BR BRPI0609704A patent/BRPI0609704B8/pt active IP Right Grant
- 2006-03-16 PL PL06710096T patent/PL1866324T3/pl unknown
- 2006-03-16 US US11/886,931 patent/US8263575B2/en active Active
- 2006-03-16 CN CN201410186829.5A patent/CN103936807A/zh active Pending
- 2006-03-16 CA CA2602324A patent/CA2602324C/en active Active
- 2006-03-16 EP EP06710096A patent/EP1866324B1/en active Active
- 2006-03-16 JP JP2008502453A patent/JP5345381B2/ja not_active Expired - Fee Related
- 2006-03-16 SI SI200630762T patent/SI1866324T1/sl unknown
- 2006-03-16 CN CNA200680016708XA patent/CN101175763A/zh active Pending
- 2006-03-16 MX MX2007011666A patent/MX2007011666A/es active IP Right Grant
- 2006-03-16 WO PCT/GB2006/000932 patent/WO2006100439A1/en active Application Filing
- 2006-03-16 AT AT06710096T patent/ATE471334T1/de active
- 2006-03-16 DE DE602006014949T patent/DE602006014949D1/de active Active
- 2006-03-16 DK DK06710096.6T patent/DK1866324T3/da active
- 2006-03-16 ZA ZA200709011A patent/ZA200709011B/xx unknown
-
2007
- 2007-09-20 IL IL186104A patent/IL186104A/en active IP Right Grant
-
2010
- 2010-09-10 CY CY20101100826T patent/CY1111538T1/el unknown
-
2013
- 2013-05-07 JP JP2013097919A patent/JP5863702B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
CA2602324C (en) | 2015-02-24 |
IL186104A0 (en) | 2008-01-20 |
JP5345381B2 (ja) | 2013-11-20 |
WO2006100439A1 (en) | 2006-09-28 |
IL186104A (en) | 2013-06-27 |
BRPI0609704B8 (pt) | 2021-09-28 |
EP1866324A1 (en) | 2007-12-19 |
DE602006014949D1 (de) | 2010-07-29 |
US8263575B2 (en) | 2012-09-11 |
AU2006226182B2 (en) | 2011-09-01 |
AU2006226182A1 (en) | 2006-09-28 |
BRPI0609704B1 (pt) | 2020-12-01 |
ATE471334T1 (de) | 2010-07-15 |
JP5863702B2 (ja) | 2016-02-17 |
DK1866324T3 (da) | 2010-09-27 |
AU2006226182C1 (en) | 2012-06-14 |
CN101175763A (zh) | 2008-05-07 |
PT1866324E (pt) | 2010-09-16 |
CN103936807A (zh) | 2014-07-23 |
SI1866324T1 (sl) | 2010-10-29 |
MX2007011666A (es) | 2007-11-14 |
CA2602324A1 (en) | 2006-09-28 |
JP2008533191A (ja) | 2008-08-21 |
US20090215715A1 (en) | 2009-08-27 |
CY1111538T1 (el) | 2015-08-05 |
EP1866324B1 (en) | 2010-06-16 |
JP2013173786A (ja) | 2013-09-05 |
ZA200709011B (en) | 2009-01-28 |
PL1866324T3 (pl) | 2010-12-31 |
BRPI0609704A2 (pt) | 2010-04-20 |
ES2348741T3 (es) | 2010-12-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0505781D0 (en) | Chemical compounds | |
MX2009008222A (es) | Antagonistas de activina-actriia y usos para tratar o prevenir cancer de mama. | |
TW200737269A (en) | Ion sources, systems and methods | |
TW200612918A (en) | Lonidamine analogs | |
MY146112A (en) | Long-term feed - cancer patient | |
SG164368A1 (en) | Treatment of cancer | |
IL190796A0 (en) | Compositions and their uses for gene therapy of bone conditions | |
BRPI0611670A2 (pt) | método para o tratamento ou prevenção de câncer em um indivíduo | |
TW200716141A (en) | Compositions and methods for treatment for neoplasms | |
MX2009010899A (es) | Prediccion de la supervivencia al post-tratamiento en pacientes de cancer con micro-rnas. | |
MX2009006536A (es) | Compuestos de heteroaril-heteroarilo como inhibidores de cdk para el tratamiento de cancer, inflamacion e infecciones virales. | |
WO2007064872A3 (en) | Urea compounds useful in the treatment of cancer | |
MX2010004109A (es) | 2'-fluoro-2'-desoxitetrahidrouridinas como inhibidores de citidina desaminasa. | |
MX2009004986A (es) | Metodos de tratamiento de anemia hemolitica. | |
MY147247A (en) | Organic compounds and their uses | |
WO2007053573A3 (en) | Treatment of cancer with sorafenib | |
TW200715634A (en) | Stable organic devices | |
TW200716088A (en) | Formulations and methods for treating amyloidosis | |
TW200605586A (en) | Flexible accelerators for physical layer processing | |
MD3393478T2 (ro) | Terapie combinată | |
WO2009009034A3 (en) | Methods and compositions useful in the treatment of mucositis | |
NO20074780L (no) | Heterocyklylamidsubstituerte imidazoler | |
WO2009032172A3 (en) | Platinum compositions as treatment for oct-related cancers | |
MX2010005324A (es) | Composiciones y metodos para inhibir el avance del tumor. | |
CA3156667A1 (en) | OLIGONUCLEOTIDES INCLUDING NUCLEOSIDE ANALOGS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |